Valneva SE (VALN) Tax Provisions (2021 - 2026)
Valneva SE (VALN) posted Tax Provisions of $936596.5 for Q1 2026, up 180.46% sequentially from -$1.2 million in Q4 2025, and down 40.64% YoY from $1.6 million in Q1 2025.
Valneva SE (VALN) Tax Provisions (2021 - 2026) Analysis & Trends
Valneva SE has reported Tax Provisions for 6 years, with the latest figure at $936596.5 in Q1 2026.
- Quarterly Tax Provisions fell 40.64% year-over-year to $936596.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $481405.1 (down 79.26% YoY) and the FY2025 annual result came in at $1.3 million, up 47.88% from the prior year.
- Tax Provisions improved to $936596.5 in Q1 2026 per VALN's latest filing, from -$1.2 million in the prior quarter.
- Over five years, Tax Provisions peaked at $2.2 billion in Q3 2022 and troughed at -$2.2 billion in Q4 2022.
- A 5-year average of -$1.3 million and a median of $413954.9 in 2023 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 188799.55% in 2022, down 38003.7% in 2022.
- Over 5 years, Tax Provisions stood at -$2.2 billion in 2022, then surged by 100.19% to $4.2 million in 2023, then advanced by 19.69% to $5.0 million in 2024, then plunged by 123.18% to -$1.2 million in 2025, then jumped by 180.46% to $936596.5 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $936596.5, -$1.2 million, and $935244.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn | -630,000.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -630,000.12 |
| Mar 31, 2026 | 936,596.52 |
| Dec 31, 2025 | -1.16 Mn |
| Sep 30, 2025 | 935,244.07 |
| Jun 30, 2025 | -226,391.94 |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Sep 30, 2024 | -4.06 Mn |
| Jun 30, 2024 | -215,377.52 |
| Dec 31, 2023 | 4.20 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | -4.01 Mn |
| Mar 31, 2023 | -107,334.18 |
| Dec 31, 2022 | -2.21 Bn |
| Sep 30, 2022 | 2.18 Bn |
| Jun 30, 2022 | 2.99 Mn |
| Mar 31, 2022 | -563,413.53 |
| Dec 31, 2021 | 5.83 Mn |
| Sep 30, 2021 | -1.15 Mn |
| Jun 30, 2021 | -1.25 Mn |